ArticleslgStudy

physics

Pegulicianine

Pegulicianine is a physics topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Pegulicianine rather than just read about it. In short: Pegulicianine, sold under the brand name Lumisight, is an optical imaging agent. It is given via intravenous injection.

Pegulicianine — main illustration
Pegulicianine — illustration

Key takeaways

  • Pegulicianine belongs to physics; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Pegulicianine to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Pegulicianine from memory before moving on to harder problems.

Reference excerpt

Pegulicianine, sold under the brand name Lumisight, is an optical imaging agent. It is given via intravenous injection. Pegulicianine was approved for medical use in the United States in April 2024. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication.

Medical uses Pegulicianine is indicated for fluorescence imaging in adults with breast cancer as an adjunct for the intraoperative detection of cancerous tissue within the resection cavity following removal of the primary specimen during lumpectomy surgery.

Mechanism of action Pegulicianine is non-fluorescent in its intact parent form. However, in breast cancer tissue, where cathepsins and matrix metalloproteinases are overexpressed, it is enzymatically cleaved into two fragments, one of which is fluorescent. Pegulicianine consists of the following four components that are covalently linked to each other:

A far-red cyanine dye known as Cy5, which has a peak absorption near 650 nm and emission around 675 nm, allowing detection by imaging systems. A non-fluorescent chromophore called QSY21 (a rhodamine derivative), which functions as a fluorescence quencher. QSY21 absorbs the emission from Cy5, suppressing fluorescence until enzymatic cleavage occurs. A tripeptide linker (Gly-Gly-Arg), which is cleaved by tumor-associated proteases (cathepsins and matrix metalloproteinases). Once cleaved, Cy5 is released from proximity to QSY21, restoring its fluorescence. A polyethylene glycol (PEG) side chain that enhances water solubility, protects the molecule from enzymatic degradation, extends circulation time by increasing its hydrodynamic radius—thereby reducing renal clearance—and lowers immunogenicity.

History The efficacy and safety of pegulicianine were evaluated in a multicenter, intra-participant controlled clinical trial (NCT03686215) of participants with breast cancer undergoing lumpectomy surgery. A total of 357 participants underwent image-guided surgery with the Lumicell DVS following standard of care lumpectomy. When positive pegulicianine signal was detected, the tissue was resected with a cavity shave procedure. The study assessed the proportion of participants receiving pegulicianine who had residual cancer detected and removed after the standard of care lumpectomy. A total of 27 of 357 participants (7.6%) had cancer in at least one pegulicianine-guided shave. The study also assessed the image-level sensitivity (ability to designate an imaged region with disease as positive) and specificity (ability to designate an imaged region without disease as negative) for detection of cancer in the lumpectomy cavity. Sensitivity was 49.1% and specificity was 86.5%. Forty-three percent (43%) of participants had at least one false positive image and 8% of participants had at least one false negative image.

Society and culture

Legal status Pegulicianine was approved for medical use in the United States in April 2024. The US Food and Drug Administration granted the application for pegulicianine fast track and priority review designations.

Names Pegulicianine is the international nonproprietary name.

References

External links Clinical trial number NCT03686215 for "Investigation of Novel Surgical Imaging for Tumor Excision (INSITE)" at ClinicalTrials.gov

Illustrations

Pegulicianine illustration

Worked examples

Example 1 — a first encounter with Pegulicianine

Start with the simplest possible case. Write down what Pegulicianine claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In physics, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Pegulicianine before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Pegulicianine ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Pegulicianine

In research
Pegulicianine appears in physics research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Pegulicianine in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Pegulicianine is common in secondary-school and first-year university syllabi. It links to neighbouring topics Optical imaging, Peptides, Sulfonamides, so understanding it makes those chapters shorter.
In everyday life
Look for Pegulicianine outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Pegulicianine” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Pegulicianine in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Pegulicianine means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Pegulicianine out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Pegulicianine in simple terms?

Pegulicianine, sold under the brand name Lumisight, is an optical imaging agent. It is given via intravenous injection.

Why does Pegulicianine matter?

Because it connects several physics ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Pegulicianine?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Pegulicianine.

Tags

  • Optical imaging
  • Peptides
  • Sulfonamides

Keep exploring